CELGENE CORP /DE/ 4
4 · AGIOS PHARMACEUTICALS, INC. · Filed Nov 14, 2019
Insider Transaction Report
Form 4
CELGENE CORP /DE/
10% Owner
Transactions
- Purchase
Common Stock
2019-11-12$31.00/sh+403,225$12,499,975→ 1,777,824 total
Holdings
- 624,575(indirect: See footnote)
Common Stock
- 708,333(indirect: See footnote)
Common Stock
- 4,010,926(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Owned directly by Celgene Switzerland LLC, a wholly-owned subsidiary of Celgene Corporation ("Celgene"). Celgene and the other reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
- [F2]Owned directly by Celgene European Investment Company LLC, a wholly-owned subsidiary of Celgene. Celgene and the other reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
- [F3]Owned directly by Celgene Alpine Investment Co., LLC, a wholly-owned subsidiary of Celgene. Celgene and the other reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.